Sg Americas Securities, LLC Forma Therapeutics Holdings, Inc. Transaction History

Sg Americas Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$7.12 - $20.24 $43,738 - $124,334	6,143 New	6,143 $123,000
Q1 2022 Apr 29, 2022	SELL	$8.34 - $14.69 $82,857 - $145,945	-9,935 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$13.6 - $24.89 $188,863 - $345,647	-13,887 Reduced 58.29%	9,935 $141,000
Q3 2021 Nov 01, 2021	BUY	$21.22 - $25.7 $505,502 - $612,225	23,822 New	23,822 $552,000
Q2 2021 Aug 12, 2021	SELL	$22.86 - $30.95 $153,299 - $207,550	-6,706 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$24.58 - $42.82 $164,833 - $287,150	6,706 New	6,706 $188,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.